R
Richard L. Boortz-Marx
Researcher at Duke University
Publications - 23
Citations - 1708
Richard L. Boortz-Marx is an academic researcher from Duke University. The author has contributed to research in topics: Heart failure & Opioid receptor. The author has an hindex of 13, co-authored 23 publications receiving 1393 citations. Previous affiliations of Richard L. Boortz-Marx include Durham University & Virginia Commonwealth University.
Papers
More filters
Journal ArticleDOI
Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival
Thomas J. Smith,Peter S. Staats,Timothy Deer,Lisa Stearns,Richard L. Rauck,Richard L. Boortz-Marx,Eric Buchser,Elena Catala,David A. Bryce,Patrick J. Coyne,George E. Pool +10 more
TL;DR: IDDSs improved clinical success in pain control, reduced pain, significantly relieved common drug toxicities, and improved survival in patients with refractory cancer pain.
Journal ArticleDOI
Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections.
Kenneth A. Follett,Richard L. Boortz-Marx,James M. Drake,Stuart DuPen,Steven J. Schneider,Steven J. Schneider,Michael S. Turner,Robert J. Coffey +7 more
TL;DR: Management of infections associated with DD and SCS systems typically involves administration of antibiotics and explantation of the devices, and measures that reduce the incidence of other SSIs also should reduce the infection rate associated with the implantation of SCS and intrathecal DD devices.
Journal ArticleDOI
An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)
Thomas J. Smith,Patrick J. Coyne,P. S. Staats,T. Deer,L. J. Stearns,R. L. Rauck,Richard L. Boortz-Marx,E. Buchser,E. Català,D. A. Bryce,Michael J. Cousins,G. E. Pool +11 more
TL;DR: IDDS improved clinical success, reduced pain scores, relieved most toxicity of pain control drugs, and was associated with increased survival for the duration of this 6 month trial.
Journal Article
Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
Lisa Stearns,Richard L. Boortz-Marx,Stuart Du Pen,Gerhard Friehs,Michael S Gordon,Michelle Halyard,Laurel Herbst,Jennifer Kiser +7 more
TL;DR: Increased understanding of available options for truly effective pain management in the oncology and palliative care arena and the benefits of multidisciplinary cooperation will translate into genuine improvements in patient quality of life and a measurable decrease in the number of patients who suffer needlessly in their final days.
Journal ArticleDOI
μ-Opioid Receptor Gene A118G Polymorphism Predicts Survival in Patients with Breast Cancer
Andrey V. Bortsov,Robert C. Millikan,Inna Belfer,Richard L. Boortz-Marx,Harendra Arora,Samuel A. McLean +5 more
TL;DR: The association between six common polymorphisms in the &mgr;-opioid receptor gene, including the well known A118G polymorphism, and breast cancer survival and opioid pathways may be involved in tumor growth is assessed.